Someone sent me this from the XBIZ forum .
Michelle LeBlanc, Head OF FSC
“TTS has chosen to withdraw from PASS in order to pursue business decisions and performer testing requirements that are not in accordance with PASS testing requirements.
We’ve asked TTS to remain a part of PASS and to resume sending results to PASS and they have refused.”
” TTS is able to offer their proprietary COVID test at $35/$75 because it has not yet received full FDA approval, and is being administered under FDA Emergency Use Authorization (EUA). If it receives full FDA approval, it will cost ~$100 because that is the price mandated by the FDA to prevent both price gauging and undercutting competitors.”
Of course when I asked people at FSC about this they acted like I didn’t know what i was talking about
Leave a Comment